In the setting of ischemic stroke, however, blocking GPIIb/IIIa in an experimental stroke model markedly increased the risk of intracerebral hemorrhage and mortality and surviving animals still showed infarct volumes that were in the range of control treated mice. Here, ITGA2B is linked to intracerebral hemorrhage.